Skip to content

Clinical trials

Hyperglycemia trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperglycemia Country / region: South Korea Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20083
20093
20122
20174
20181
20191
20201
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status4
Not yet recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi4
Chonbuk National University Hospital3
Asan Medical Center2
GlaxoSmithKline2
Seoul National University Hospital2
Boehringer Ingelheim1
Catholic Kwandong University1
Korea University1
Korea University Anam Hospital1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperglycemia20
Diabetes Mellitus, Type 212
Insulin Resistance4
Diabetes Mellitus2
Glucose Intolerance2
Hypoglycemia2
Acute Kidney Injury1
Diabetic Retinopathy1
End Stage Liver Disease1
Heart Failure1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.